BMRNBiomarin Pharmaceutical Inc. - Registered Shares
$59.20
$0.08
(0.14%)
Today
·Closed $59.20
$0.00
(0.00%)
After Hours
EarningsAug 3
Mkt Cap$11.43B
Vol1.59M
About
BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
3,221
Frequently Asked Questions
What is Market Cap of Biomarin Pharmaceutical Inc. - Registered Shares?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Biomarin Pharmaceutical Inc. - Registered Shares market cap is $11.43B.
What is the 52-week high for Biomarin Pharmaceutical Inc. - Registered Shares?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biomarin Pharmaceutical Inc. - Registered Shares 52 week high is $66.28 as of July 13, 2026.
What is the 52-week low for Biomarin Pharmaceutical Inc. - Registered Shares?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biomarin Pharmaceutical Inc. - Registered Shares 52 week low is $49.26 as of July 13, 2026.
What is Biomarin Pharmaceutical Inc. - Registered Shares stock price today?
Biomarin Pharmaceutical Inc. - Registered Shares stock price today is $59.20.
What was Biomarin Pharmaceutical Inc. - Registered Shares stock price yesterday?
Biomarin Pharmaceutical Inc. - Registered Shares stock price yesterday was $59.12.
What is the PE ratio of Biomarin Pharmaceutical Inc. - Registered Shares?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Biomarin Pharmaceutical Inc. - Registered Shares's P/E ratio is 43.14.
What is the Price-to-Book ratio of Biomarin Pharmaceutical Inc. - Registered Shares?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Biomarin Pharmaceutical Inc. - Registered Shares P/B ratio is 1.8393.
What is the 50-day moving average of Biomarin Pharmaceutical Inc. - Registered Shares?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Biomarin Pharmaceutical Inc. - Registered Shares 50-day moving average is $55.31.
How many employees does Biomarin Pharmaceutical Inc. - Registered Shares have?
Biomarin Pharmaceutical Inc. - Registered Shares has 3,221 employees.